- presents a secure and clear setting for compounding of hazardous drug preparations in compliance with USP and criteria. It is actually suited to operate involving hazardous materials, antineoplastic, or cytotoxic compounding purposes. The risk management course of action begins with a radical analysis of prospective failure modes and their